Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The US FDA is alerting pet owners and veterinarians of the possible adverse neurological events to cats and dogs associated with isoxazoline flea and tick products.
Covenant Animal Health Partners has been launched to focus on bringing animal health innovations to market.
Bayer Animal Health's Seresto flea and tick collar has recently been licensed in several European countries to reduce the risk of canine leishmaniasis.
Piedmont Animal Health and Norbrook Laboratories are among several firms to have gained recent product approvals from the US FDA.
Zoetis is aiming to get approval for a new three-way combination parasiticide, with launches penciled in for 2020.
Zoetis' Equitape praziquantel-only wormer for horses will be discontinued from the firm's equine product range in October 2018.
Boehringer Ingelheim Animal Health's NexGard antiparasitic chewable tablet for dogs has gained a supplemental approval from the US FDA for the prevention of a bacterial infection.
Animal Pharm is looking for new authors for its animal health industry reports team.
New research has outlined the potential of repurposing common veterinary antiparasiticides for the control of human vector-borne diseases.
Last year, TyraTech did the opposite of many companies and offloaded its human health business. Now with a focus on animal health, the Morrisville, North Carolina-based firm can pursue a more disciplined growth strategy. Animal Pharm editor Joseph Harvey spoke to the company's chief executive Bruno Jactel.
Boehringer Ingelheim Animal Health has secured Japanese approval for Zactran (gamithromycin) as an antibiotic treatment of swine respiratory disease.
Bayer Animal Health has teamed up with Japanese firm Mitsui Chemicals Agro (MCAG) in its search for novel parasite prevention.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.